Concepedia

Carolyn M. Hustad

CM

Statistics

Publications

38

Citations

3.3K

H-Index

29

Active since

1994

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

Cancer Research Center

United States Military Academy

MSD (Belgium)

The University of Texas MD Anderson Cancer Center

Carolyn M. Hustad is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in medicine, gene expression, and genetics.

Top concepts

Publications per year

1994–2017

38

Publications

38

Efficacy and Tolerability of Aprepitant for the Prevention of Chemotherapy-Induced Nausea and Vomiting in Patients With Breast Cancer After Moderately Emetogenic Chemotherapy

David Warr, Paul J. Hesketh, Richard J. Gralla et al. · Journal of Clinical Oncology · 2005 · 464 citations

Odanacatib, a cathepsin-K inhibitor for osteoporosis: A two-year study in postmenopausal women with low bone density

Henry G. Bone, Michael R. McClung, Christian Roux et al. · Journal of Bone and Mineral Research · 2009 · 330 citations

, , +16

The itchy locus encodes a novel ubiquitin protein ligase that is disrupted in a18H mice

William L. Perry, Carolyn M. Hustad, Debra A. Swing et al. · Nature Genetics · 1998 · 329 citations

, , +9

Odanacatib in the treatment of postmenopausal women with low bone mineral density: Three-year continued therapy and resolution of effect

John A. Eisman, Henry G. Bone, David Hosking et al. · Journal of Bone and Mineral Research · 2010 · 246 citations · Full text

A Mef2 gene that generates a muscle-specific isoform via alternative mRNA splicing.

James F. Martin, Joseph M. Miano, Carolyn M. Hustad et al. · Molecular and Cellular Biology · 1994 · 218 citations · Full text

, , +22

Rows per page

1–5 of 38